Aims The lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) and its shedding
product [soluble LOX-1 (sLOX-1)] are implicated in atherosclerotic cardiovascular disease …

Background: Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is implicated in
atherosclerotic plaque vulnerability. It is shed, in part, by proteases and released as soluble …

Background: Cardiac troponin is the best marker to diagnose acute coronary syndrome
(ACS). However, early diagnosis using markers for plaque instability may be of significance …

Background Angiographic coronary lesion complexity has been reported to predict plaque
vulnerability. It is important to develop a noninvasive blood biomarker for accurate …

Background—Markers of cardiac injury, including troponin-T (TnT), are used to diagnose
acute coronary syndrome (ACS); however, markers for plaque instability may be more useful …

Lectin‐like oxidized low density lipoprotein receptor‐1 (LOX‐1), the main oxidized low‐
density lipoprotein (OxLDL) in endothelial cells, is upregulated in atherosclerotic lesions and …

Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), a scavenger receptor of
oxidized low-density lipoprotein (ox-LDL) found in various cells, plays a crucial role in the …

BACKGROUND: Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) appears to
be involved in atherosclerotic plaque vulnerability and rupture. Circulating soluble LOX-1 …

BACKGROUND:: Although serum soluble lectin-like oxidized low-density lipoprotein
receptor-1 (sLOX-1) is reported to be associated with acute coronary syndrome (ACS), its …

Lectin-like oxidized-low-density lipoprotein receptor-1 (LOX-1) is increasingly linked to
atherosclerotic plaque formation and the soluble form of this receptor may reflect activities of …